Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann
Clinical trial NCT04891835 · COMPLETED
Trial details
- NCT number
- NCT04891835
- Sponsor
- Laurence Postelmans
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-13
- Primary completion
- 2021-09-22
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.